Abstract
Thirty-seven patients with newly diagnosed or treated sarcomas had 47 sets of sequential thallium scans (TS) followed by three-phase bone scan (TPBS) on the same day. The diagnosis in all patients was verified by biopsy (n=40) or long-term follow-up studies (n=7). The sensitivity, specificity, and accuracy of TS and TPBS in detecting sarcomatous lesions was calculated: TS sensitivity was 88%, specificity 69%, and accuracy 83%; blood flow (BF) and blood pool (BP) sensitivity was 91%, specificity 54%, and accuracy 81 %; delayed bone scan (DB) sensitivity was 88%, specificity 38%, and accuracy 74%. In 17 studies the flow and blood pool parts of the TPBS and TS demonstrated the soft tissue component of sarcomas, which would have been missed if only the delayed bone scan had been performed. The TS lesion to normal tissue ratio alone was not very helpful in differentiating sarcomas from benign conditions because some benign lesions are highly cellular and vascular while some malignant lesions, such as chondrosarcoma, have poor vascularity and a less cellular chondroid matrix. However, when the thallium ratio was correlated with similar ratios calculated from yhe BP image, it was found that if the TS lesion to normal tissue ratio exceeded the BP lesion to normal tissue ratio (12 patients), the specificity for detecting sarcomatous lesions was 100%. Nevertheless, the reverse was not true. The positive predictive value of this observation was 100% and the negative predictive value was 37%.
Similar content being viewed by others
References
Enneking WG, Chew FC, Springfield DS, Hudson TM, Spanier SS. The role of radionuclide bone-scanning in determining the resectability of soft-tissue sarcomas. J Bone Joint Surg [Am] 1981; 63: 249–257.
Hortobagyi GN, Libshitz HI, Seabold JE. Osseous metastases of breast cancer. Cancer 1984; 53: 577–582.
McNeil BJ. Rationale for the use of bone scans in selected metastatic and primary bone tumors. Semin Nucl Med 1978; 8: 336–345.
McKillop JH, Etcubanas E, Goris ML. The indications for and limitations of bone scintigraphy in osteogenic sarcoma: review of 55 patients. Cancer 1981; 48: 1133–1138.
Tonami N, Hisada K. Clinical experience of tumor imaging with T1–201 chloride. Clin Nucl Med 1977; 2: 75–81.
Tonami N; Michigishi T, Banko H, et al. Clinical tumor scanning with T1–201 chloride [abstract]. J Nucl Med 1977; 18: 617.
Salvatore M, Carrati L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology 1976; 167: 487–488.
Cox PH, Belfer AJ, Van der Pompe WB. T1–201 chloride uptake in tumours: a possible complication in heart scintigraphy. Br J Radiol 1976; 49: 767–768.
Sehweil AM. An evaluation of thallium-201 as a tumor imaging agent. PhD thesis. Glasgow University. 1988.
Sehweil A, El Sayed M, Ziada G, et al. Thallium 201 kinetics in malignant tumors [abstract]. J Nucl Med 1986; 27: 1033.
Sehweil A, McKillop JH, Ziada C, Abdel-Dayem HM. The optimum time for tumor imaging with T1–201. Eur J Nucl Med 1988;13:527–529.
Sehweil A, Mckillip JH, Milroy R, et al. Mechanism of T1–201 uptake in tumours. Eur J Nucl Med 1989; 15: 376–379.
Kaplan WD, Takuorian T, Morris JH, et al. T1–201 brain tumor imaging: a comparative study with pathologic correlation. J Nucl Med 1987; 29: 47–52.
Gruber ML, Hockberg FH. Systemic evaluation of primary brain tumors (editorial). J Nucl Med 1990; 31: 969–971.
Hoefnagel CA, Delprat CC, Zanin D, van der Schoot JB. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med 1988; 13: 159–165.
Ramanna L, Waxman AD, Brachman MB, Tanasescu DE, Bernstein G. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum alupoglobulin determinations. J Nucl Med 1991; 32: 441–446.
Eisenberg B, Velchik MG, De Vries DF Thallium-201 chloride uptake in a lung tumor during a routine stress thallium examination. Clin Nucl Med 1988; 13: 214–215.
Klier S, Heo J, Iskandrian AS. Massive extracardiac thallium accumulation in pulmonary carcinoma [letter]. Clin Nucl Med 1988;93:672.
Tagawa T, Sujuki A, Kato K. Relation between T1–201 to Ga-67 uptake ratio and histological type in primary lung cancer. Eur J Cancer Clin Oncol 1977; 4: 487–488.
El-Gazzar AH, Malki AA, Abdel-Dayem HM, et al. Role of thallium-201 in the diagnosis of solitary bone lesions. Nucl Med Commun 1989; 10: 477–485.
Terui S, Oyamada H, Nishikawa K, Beppu Y, Fukama H. T1–201 chloride scintigraphy for bone tumors and soft part sarcomas [abstract]. J Nucl Med 1984; 25: P114.
Waxman AD, McKee D, Siesem JK, Singer FR. Gallium scanning in Paget's disease of bone. AJR 1980; 134: 303–306.
Ramanna L, Waxman AD, Waxman S, et al. TI-201 scintigraphy in bone and soft-tissue sarcoma: evaluation of tumor mass and viability [abstract]. J Nucl Med 1988; 29: 854.
Ramanna L, Waxman AD, Binney G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1988; 31: 567–572.
Ramanna L, Waxman AD, Rosen G. Evaluation of T1–201 (T1) uptake pattern in bone lesions: differentiation of benign from malignant processes [abstract]. J Nucl Med 1992; 33: 869.
Caluser C, Macapinlac HA, Healey J, et al. The relationship between thallium uptake, blood flow, and blood pool activity in bone and soft tissue tumors. Clin Nucl Med 1992; 17: 565–571.
Rosen G, Capparos G, Nirenberg A, et al. Ewing's sarcoma: a ten year experience with adjuvant chemotherapy. Cancer 1981;47:2204–2213.
Rosen G, Capparos B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based upon the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221–1230.
Chaudary MA, Maisey MN, Shaw PJ, Rubens RD, Hayard JL. Sequential bone scans and chest radiographs in the postoperative management of early breast cancer. Br J Surg 1983; 70: 517–518.
Levenson RM, Sauerbrunn BJ, Bates HR, Newman RD, Eddy JL, Ihde DC. Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma. Radiology 1983; 146: 513–518.
Rossleigh MA, Lovegrove FTA, Reynolds PM, Byrne MJ. Serial bone scans in the assessment of response to therapy in advanced breast carcinoma. Clin Nucl Med 1982; 7: 397–402.
Pollen JJ, Witztum KF, Asburn WL. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer. AJR 1984;142:773–776.
Sessler M, Manol FD, Geck P, et al. Kinetics and mechanism of T1 uptake in malignant tumours in vivo and in vitro. Nuclear medicine and biology proceedings, 3rd world congress of nuclear medicine and biology. Paris: Pergamon Press; 1982: 2281–2284.
Ando AA, Ando I, Katayama M, et al. Biodistribution of T1–201 in tumor bearing animals and inflammatory lesion induced animals. Semin Nucl Med 1987; 12: 567.
Britten JS, Blank M. Thallium activation of the (Na+K+) activated ATP-ase of the rabbit kidney. Biochem Biophys Acta 1968;159:160.
Caluser C, Healey T, Macapinlac H, Abdel-Dayem H, et al. T1–201 uptake in recurrent pigmented villonodular synovitis. Correlation with three phase bone imaging. Clin Nucl Med 1992;17:751–753.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caluser, C.I., Abdel-Dayem, H.M., Macapinlac, H.A. et al. The value of thallium and three-phase bone scans in the evaluation of bone and soft tissue sarcomas. Eur J Nucl Med 21, 1198–1205 (1994). https://doi.org/10.1007/BF00182353
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00182353